EarlySense Adds Healthcare Technology and Informatics Leader Stephen Kahane, M.D., M.S., to Its Board of Directors
Summary
WOBURN, Massachusetts, June 25, 2019 /PRNewswire/ -- EarlySense, the market leader in contact-free continuous monitoring and analytics solutions across the care continuum, announced today the appointment of Stephen Kahane, M.D., M.S., to its board of directors. "We are pleased to welcome Dr. Kahane to our board of directors and look forward to leveraging his insights to better serve healthcare providers in combining our proven contact-free continuous monitoring patient-care solution with advanced analytics to protect patient lives," said Matt Johnson, CEO, EarlySense. Previously, Dr. Kahane served as President of Client Organization at athenahealth, and as CEO of AMICAS, a publicly traded imaging and information management company. "I am eager to support EarlySense and its clients to improve patient care and reduce costs in healthcare institutions worldwide." EarlySenses FDA-cleared solutions leverage big data analytics to provide actionable health insights and improve clinical outcomes.
Classifications
AskAI Classifications
LabelsLinked Companies
